XTNT — Xtant Medical Holdings, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on XTNT
| date | signal | measured base rate |
|---|---|---|
| 2026-04-22 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-15 | Neils Scott C CFO and Assistant Secretary | Shares withheld for tax | 28.2K | 0.31 | 8.7K |
| 2026-08-15 | Browne Sean E President and CEO | Shares withheld for tax | 10.6K | 0.31 | 3.3K |
| 2026-08-15 | Schallenberger Mark A. Chief Operating Officer | Shares withheld for tax | 7.1K | 0.31 | 2.2K |
| 2026-08-15 | Browne Sean E President and CEO | Grant or award | 550.0K | 0.00 | 0 |
| 2026-08-15 | Lipschultz Tyler Director | Grant or award | 215.5K | 0.00 | 0 |
| 2026-08-15 | Neils Scott C CFO and Assistant Secretary | Grant or award | 400.0K | 0.00 | 0 |
| 2026-08-15 | JAIN ABHINAV Director | Grant or award | 215.5K | 0.00 | 0 |
| 2026-08-15 | Schallenberger Mark A. Chief Operating Officer | Grant or award | 450.0K | 0.00 | 0 |
| 2026-08-15 | Beeson Jonn R. Director | Grant or award | 215.5K | 0.00 | 0 |
| 2026-08-15 | BAKEWELL JOHN K Director | Grant or award | 215.5K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Nantahala Capital Management, LLC | 38.2M | 68.4M |
| AWM Investment Company, Inc. | 3.3M | 6.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | 2.0M |
| RENAISSANCE TECHNOLOGIES LLC | 551.0K | 987.4K |
| GEODE CAPITAL MANAGEMENT, LLC | 295.4K | 529.2K |
| Crescent Grove Advisors, LLC | 229.9K | 412.0K |
| Hillsdale Investment Management Inc. | 202.1K | 362.2K |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 195.3K | 350.0K |
| VANGUARD FIDUCIARY TRUST CO | 144.0K | 258.0K |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 91.6K | 164.1K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Xtant Medical (XTNT) Q2 2026 Earnings Call Transcript · 2026-08-12
- Xtant Medical misses top-line and bottom-line estimates; lowers FY2026 outlook · 2026-08-11
- Xtant Medical Holdings, Inc. (XTNT) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about XTNT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →